Selventa signs research agreement with Janssen
The companies will develop disease models using diverse biologic data to elaborate disease-relevant mechanisms and find out potential new drug discovery opportunities. Selventa will leverage molecular patient data
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.